DR HARALAMBIDIS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DR HARALAMBIDIS
Largest movements
- Cash +€120,329
up €120,329 (+7.4%), from €1.6m to €1.7m
mainly Net result for the year (+€347,238) and Depreciation (+€9,327)
- Reserves +€126,050
up €126,050 (+9.3%), from €1.4m to €1.5m
- Gross operating margin +€31,773
up €31,773 (+6.6%), from €484,264 to €516,037
- Taxes +€15,574
up €15,574 (+10.5%), from €147,651 to €163,225
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,654,513 | €1,773,791 | +€119,278 | +7.2% |
| Fixed assets | 21/28 | €10,194 | €866 | -€9,327 | -91.5% |
| Tangible fixed assets | 22/27 | €10,194 | €866 | -€9,327 | -91.5% |
| Furniture and vehicles | 24 | €10,194 | €866 | -€9,327 | -91.5% |
| Current assets | 29/58 | €1,644,319 | €1,772,924 | +€128,605 | +7.8% |
| Amounts receivable within one year | 40/41 | €234 | €8,786 | +€8,552 | +3,662% |
| Trade receivables | 40 | €234 | - | -€234 | |
| Other amounts receivable | 41 | - | €8,786 | +€8,786 | |
| Cash at bank and in hand | 54/58 | €1,627,982 | €1,748,311 | +€120,329 | +7.4% |
| Deferred charges and accrued income | 490/1 | €16,104 | €15,828 | -€276 | -1.7% |
| Total equity and liabilities | 10/49 | €1,654,513 | €1,773,791 | +€119,278 | +7.2% |
| Equity | 10/15 | €1,391,458 | €1,517,508 | +€126,050 | +9.1% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €1,362,246 | €1,488,295 | +€126,050 | +9.3% |
| Distributable reserves | 133 | €1,362,246 | €1,488,295 | +€126,050 | +9.3% |
| Profit (loss) carried forward | 14 | €16,813 | €16,813 | = | 0.0% |
| Amounts payable | 17/49 | €263,055 | €256,283 | -€6,772 | -2.6% |
| Amounts payable within one year | 42/48 | €263,055 | €256,283 | -€6,772 | -2.6% |
| Trade debts | 44 | €1,910 | €371 | -€1,539 | -80.6% |
| Suppliers | 440/4 | €1,910 | €371 | -€1,539 | -80.6% |
| Taxes, remuneration and social security | 45 | €58,056 | €45,783 | -€12,273 | -21.1% |
| Taxes | 450/3 | €58,056 | €45,783 | -€12,273 | -21.1% |
| Other amounts payable | 47/48 | €203,089 | €210,129 | +€7,040 | +3.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,665 | €9,327 | -€337 | -3.5% |
| Other operating charges | 640/8 | €1,380 | €1,791 | +€411 | +29.7% |
| Gross operating margin | 9900 | €484,264 | €516,037 | +€31,773 | +6.6% |
| Operating profit (loss) | 9901 | €473,219 | €504,919 | +€31,700 | +6.7% |
| Financial income | 75/76B | €1,962 | €5,795 | +€3,832 | +195% |
| Recurring financial income | 75 | €1,962 | €5,795 | +€3,832 | +195% |
| Financial charges | 65/66B | €459 | €251 | -€207 | -45.2% |
| Recurring financial charges | 65 | €459 | €251 | -€207 | -45.2% |
| Profit (loss) for the period before taxes | 9903 | €474,723 | €510,462 | +€35,739 | +7.5% |
| Income taxes | 67/77 | €147,651 | €163,225 | +€15,574 | +10.5% |
| Profit (loss) for the period | 9904 | €327,072 | €347,238 | +€20,165 | +6.2% |
| Profit (loss) for the period to be appropriated | 9905 | €327,072 | €347,238 | +€20,165 | +6.2% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.